CP c.884A>C ;(p.H295P)

Variant ID: 3-148925302-T-G

NM_000096.3(CP):c.884A>C;(p.H295P)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors.

Haematologica
Russo Rossi, Antonella A; Breccia, Massimo M; Abruzzese, Elisabetta E; Castagnetti, Fausto F; Luciano, Luigiana L; Gozzini, Antonella A; Annunziata, Mario M; Martino, Bruno B; Stagno, Fabio F; Cavazzini, Francesco F; Tiribelli, Mario M; Visani, Giuseppe G; Pregno, Patrizia P; Musto, Pellegrino P; Fava, Carmen C; Sgherza, Nicola N; Albano, Francesco F; Rosti, Gianantonio G; Alimena, Giuliana G; Specchia, Giorgina G
Publication Date: 2013-03

Variant appearance in text: CP: H295P
PubMed Link: 22801965
Variant Present in the following documents:
  • Main text
View BVdb publication page